BOXED WARNING Increased risk of suicidal thinking and behavior in children, adolescents, and young adults; not approved for pediatric use — monitor for clinical worsening and suicidality.
FDA dosing
Population
Start
Target
Max
Depression
Adults
15–40 mg/day divided TID–QID
60 mg/day
Depression
Adolescent / elderly
5 mg TID, titrate gradually
Renal Undefined
Hepatic Undefined
Instructions
Initiate at a low dose and increase gradually; make increases in the morning dose
In elderly, monitor cardiovascular system closely if daily dose exceeds 20 mg
Allow a minimum of 14 days after discontinuing an MAOI before starting protriptyline
Contraindications
MAOIs (concurrently or within 14 days) due to risk of hyperpyretic crises, severe convulsions, and death